BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 310 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,901,000 | +43.8% | 19,192 | +38.6% | 0.18% | +15.1% |
| Q2 2022 | $2,017,000 | +36.6% | 13,843 | +11.2% | 0.15% | +56.7% |
| Q1 2022 | $1,477,000 | +293.9% | 12,453 | +358.0% | 0.10% | +106.4% |
| Q4 2021 | $375,000 | -36.4% | 2,719 | -36.0% | 0.05% | -40.5% |
| Q3 2021 | $590,000 | -36.8% | 4,249 | -61.0% | 0.08% | -70.3% |
| Q4 2020 | $933,000 | +274.7% | 10,886 | +49.1% | 0.27% | +153.3% |
| Q1 2020 | $249,000 | – | 7,303 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |